The spike (S) protein of coronavirus is the main target for the development of vaccines and a potential strategy to counteract viral entry into human cells. The S protein forms a trimer at the protrusion of the virus and consists of two functional subunits: S1 and S2 [1]. The S protein mediates viral entry into host cells by first binding to a host receptor through the receptor-binding domain (RBD) in the S1 subunit and then fusing the viral and host membranes through the S2 subunit [2]. Neutralizing antibodies mainly target the S protein in the coronavirus, especially the S1 subunit and the RBD contained in the S1 subunit, preventing the virus from entering the host cell and causing infection.